Established Niche Portfolio Novitium Pharma specializes in developing and manufacturing niche generic pharmaceutical products, indicating opportunities to target healthcare providers and pharmacies seeking affordable, high-quality medications in specialized therapeutic areas.

Active FDA Pipeline With over 20 ANDAs filed with the FDA across diverse dosage forms and therapeutic categories, there is a strong potential to expand sales by offering new generic products aligned with market demand.

Recent Acquisition Advantage Following its acquisition by ANI Pharmaceuticals in November 2021, Novitium benefits from increased resources and distribution channels, enabling enhanced marketing and sales efforts within the pharmaceutical supply chain.

Growing Market Focus As a U.S.-based company with a focus on affordable generics, there are sales opportunities in community pharmacies, healthcare systems, and government tenders aiming to reduce medication costs while maintaining high quality.

Smaller but Agile Operating with a team of 51-200 employees and revenue between $25M and $50M, Novitium’s agile size allows for quick adaptation to market trends and customized solutions for strategic partners.